SEC Form 4 research
| Issuer | Allogene Therapeutics, Inc. |
|---|---|
| Tickers | ALLO |
| Reporting owners | 30 |
| Officers and directors | 18 |
| Last public filing | 2026-08-26 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-25 | 2026-08-21 | Douglas Earl Martin | S | 29,697 | $2.12 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.